Direct-to-Consumer (DTC) Laboratory Testing Market Report 2026

The direct-to-consumer (dtc) laboratory testing market size has grown exponentially in recent years. It will grow from $5.78 billion in 2025 to $7.52 billion in 2026 at a compound annual growth rate (CAGR) of 30%. The growth in the historic period can be attributed to limited access to clinical diagnostics, pandemic-driven testing demand, early lab digitization, rising chronic disease screening, consumer convenience preference.

The direct-to-consumer (dtc) laboratory testing market size is expected to see exponential growth in the next few years. It will grow to $18.4 billion in 2030 at a compound annual growth rate (CAGR) of 25.1%. The growth in the forecast period can be attributed to automation of laboratory workflows, ai-based diagnostics, expansion of home sample collection, regulatory acceptance, personalized health monitoring. Major trends in the forecast period include increasing adoption of at-home diagnostic testing, expansion of online test ordering platforms, growth of preventive health screening services, rising consumer demand for rapid test results, integration of digital result delivery systems.

The rising prevalence of infectious diseases is anticipated to drive the growth of the direct-to-consumer (DTC) laboratory testing market in the coming years. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi, which can be transmitted from person to person through direct contact, indirect contact, or vectors like insects or animals. The prevalence of these diseases is influenced by a combination of biological, environmental, social, and economic factors. DTC laboratory testing supports the prevention, detection, and management of infectious diseases by increasing access to testing, encouraging early intervention, and aiding public health initiatives through data collection and awareness. For example, in October 2024, the World Health Organization, a Switzerland-based international public health organization, reported that around 8.2 million people were newly diagnosed with tuberculosis in 2023, up from approximately 7.5 million in 2022, making tuberculosis the leading infectious disease killer. Consequently, the increasing prevalence of infectious diseases is propelling the growth of the DTC laboratory testing market.

Companies in the DTC laboratory testing market are concentrating on developing innovative solutions, such as mobile phlebotomy services, to improve convenience and accessibility for consumers. Mobile phlebotomy services deliver blood collection (phlebotomy) directly to a patient's location, such as their home or workplace, eliminating the need to visit a medical facility for tests. For instance, in July 2023, Quest Diagnostics Incorporated, a US-based provider of diagnostic testing, information, and services, introduced Quest Mobile, a service designed to simplify the process of specimen collection for laboratory testing nationwide. Quest Mobile allows patients to easily schedule at-home appointments with trained phlebotomists, enabling them to complete a wide range of laboratory tests from the comfort of their own homes, ensuring convenience and accessibility throughout the testing process.

In May 2023, Getlabs, a US-based provider of at-home diagnostic collections, partnered with Nice Healthcare. This strategic collaboration aims to enhance access to in-home healthcare services and lab testing, improving the overall healthcare experience for patients through combined expertise. Nice Healthcare is a US-based provider of in-home and virtual primary care services.

Major companies operating in the direct-to-consumer (dtc) laboratory testing market are Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, PerkinElmer Inc, Genesis Healthcare Co., Natera Inc, Sonora Quest Laboratories, Ancestry.com LLC, 23andMe Holding Co, Thorne HealthTech Inc, Metropolis Healthcare Limited, Color Health Inc, LetsGetChecked Inc., MyHeritage Ltd, Everlywell Inc, Complete Genomics Incorporated, DanteLabs Inc, Gene by Gene Ltd., Veritas Intercontinental, DirectLabs LLC., WellnessFX Inc, Ulta Lab Tests LLC, Any Lab Test Now Inc, Vitagene Inc.

North America was the largest region in the direct-to-consumer (DTC) laboratory testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the direct-to-consumer (dtc) laboratory testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the direct-to-consumer (dtc) laboratory testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs affect the direct-to-consumer laboratory testing market by increasing costs of imported reagents, testing kits, and laboratory instruments. North America and Europe face higher diagnostic costs due to import dependence, while emerging markets see slower adoption. These tariffs increase test pricing. However, they promote domestic manufacturing of diagnostic kits and reagents.

The direct-to-consumer (dtc) laboratory testing market research report is one of a series of new reports that provides direct-to-consumer (dtc) laboratory testing market statistics, including direct-to-consumer (dtc) laboratory testing industry global market size, regional shares, competitors with a direct-to-consumer (dtc) laboratory testing market share, detailed direct-to-consumer (dtc) laboratory testing market segments, market trends and opportunities, and any further data you may need to thrive in the direct-to-consumer (dtc) laboratory testing industry. This direct-to-consumer (dtc) laboratory testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Direct-to-consumer (DTC) laboratory testing is a model in which individuals can order medical tests and obtain their results directly, without the mandatory involvement of a healthcare provider or traditional healthcare system intermediaries. This model utilizes online platforms or services where consumers can choose from a variety of available tests, place an order, provide a specimen either at home or at a designated collection site, and receive the results electronically.

The primary samples used in direct-to-consumer (DTC) laboratory testing include blood, urine, saliva, and others. Blood samples consist of small quantities of blood collected for medical testing or analysis. These tests encompass genetic testing, disease risk assessment, complete blood count (CBC), diabetes testing, thyroid-stimulating hormone (TSH) testing, and others, serving applications such as diagnostics, research and development, and drug discovery and development, with end users including hospitals, clinics, specialty laboratories, and diagnostic centers.

The direct-to-consumer (DTC) laboratory testing market consists of revenues earned by entities by provide services such as accessibility, convenience, wellness screening, genetic testing, health monitoring, nutritional analysis, fitness and performance testing, ancestry testing, maternity testing, pharmacogenomics testing, and nutrigenomics testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The direct-to-consumer (DTC) laboratory testing market also includes sales of home test kits, sample collection kits, point-of-care testing devices, sequencing kits, automated liquid handling systems, thermal cyclers, sterile swabs, wearable devices, and mobile apps or online platforms. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.